Introducing the IMPAD project
The IMAPD team and its project are introduced in this video. The team aims to define immune-related biomarkers in the blood of patients with Parkinson's disease (PD) and hopes that they can be used as proxies for brain events, markers of progression and possible therapeutic targets in PD. Lundbeck is industry partner in the IMPAD project.
The IMPAD project is one of the 11 projects funded by the ODIN where project participants collaborate across the university-industry divide entirely without IP.
If you would like to watch the videos introducing the other projects funded by ODIN, please visit ODIN's YouTube channel.